Navigation Links
BioNeutral Signs Agreement With a Non-profit for Long-Term Removal of Formaldehyde to Save 10,000 Mobile Homes in Louisiana
Date:8/22/2008

Working with non-profit, faith-based and community organizations to

proactively get the job done

NEWARK, N.J., Aug. 22 /PRNewswire/ -- BioNeutral announced today the conclusion of an agreement with a non-profit organization to utilize its Ogiene(TM) FE technology to bring 10,000 mobile homes into full compliance so they can finally be safely used by those families so desperately in need of biohazard-free housing.

Dr. Andy Kielbania, Chief Scientist at BioNeutral, said, "All of our test data shows that Ogiene(TM) FE will be extremely effective in reducing and maintaining low levels of formaldehyde. We look forward to installing the first Ogiene(TM) FE systems in Louisiana mobile homes to bring relief to those who have endured so much suffering. Field test data will be carefully monitored and provided to the appropriate organizations."

Steve Browand, Managing Director, said, "We have authorized the human and financial resources to commence installation of our new Ogiene(TM) FE systems within the next few weeks. BioNeutral's staff will diligently work with non-profit and faith-based organizations to accelerate the availability of safe mobile homes and temporary dwellings which are currently unavailable due to formaldehyde contamination. The agreement contains special pricing which has been developed exclusively for this non-profit sector, making this a real life-saving solution to a serious problem. Our program will undoubtedly have a tremendous quality-of-life impact on the lives of over 100,000 affected families."

Visit http://www.bioneutralgroup.com to watch our Formaldehyde Videos.

About BioNeutral Laboratories Corporation

BioNeutral was organized in 2003 to commercialize a novel combinational chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses and spores. The Ygiene(TM) and Ogiene(TM) formulations are "Green" and include natural and common ingredients which are found in baby products and the foods we eat. These widely used compounds are combined in unique ways to create enhanced results.

BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. The products include BioNeutralizers and ChemoNeutralizers. BioNeutralizers disinfect, decontaminate and sterilize. BioNeutral believes it has the broadest-based, fastest acting, most effective and safest antimicrobial known. This class of products has important applications for consumers, healthcare and the military. ChemoNeutralizers irreversibly bind chemical contaminant and toxin molecules and render them harmless. Product applications include industrial pollution and protection against chemical weapons of mass destruction.

Contact Information:

BioNeutral Laboratories Corporation USA

http://www.bioneutrallabs.com

http://www.bioneutralgroup.com

Info@bioneutralgroup.com

Dr. Andy Kielbania

Chief Scientist

andy@bioneutralgroup.com

Stephen J. Browand

Director

Governmental Affairs

steve@bioneutralgroup.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE BioNeutral Laboratories Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioNeutrals Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
2. BioNeutral Laboratories Announces the Appointment of Stephen Browand as a Director to Head Military, Homeland Security and Governmental Affairs
3. BioNeutral Announces a BREAKTHROUGH in the Fight Against Bioterrorism
4. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
5. Lumidigm Signs Strategic Agreement with Methode Electronics : Automotive Supplier Invests in Biometric Component Development
6. Spherics, Inc. Assigns Assets to Joseph F. Finn, Jr., C.P.A.
7. Kiwa Bio-Tech Signs RMB 150 Million (US$21+ million) Fertilizer Contract
8. eFuture Signs Contract to Provide Tiens Group with Retail Business Management System
9. Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem Corp.
10. Senesco Signs a Supply Agreement for Polyplus-transfections Delivery System
11. Phase 3 studies show golimumab significantly improved signs and symptoms of rheumatoid arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... , ... February 20, 2017 , ... ... the re-launch of “Crosswalk Insight: Oncology™” (Crosswalk), a unique precision medicine knowledge visualization ... can now be accessed through Inspirata’s diagnostic cockpit and is downloadable as an ...
(Date:2/20/2017)... ... February 20, 2017 , ... PuraCath ... associated with peritoneal dialysis, announced today that it has published the result of ... in Peritoneal Dialysis International (PDI), the official Journal of the International Society ...
(Date:2/20/2017)...  Atrius Health and IBM (NYSE: IBM ... to develop a cloud based service designed to ... view of the multiple influences on an individual,s ... be designed to support shared decision making between ... nonprofit healthcare organization with 875 physicians caring for ...
(Date:2/18/2017)... ... February 17, 2017 , ... The BMT ... the Center for International Blood & Marrow Transplant Research (CIBMTR) will take place ... , The combined scientific sessions offer investigators, clinicians, laboratory technicians, clinical research ...
Breaking Biology Technology:
(Date:2/21/2017)... N.Y. and PORTLAND, Ore. ... ) and the Avamere Family of Companies (Avamere Health ... today announced a six-month research study that will apply ... improve eldercare at senior living and health centers. By ... Avamere hopes to gain insights into physical and environmental ...
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
(Date:2/16/2017)... FRANCISCO , Feb. 16, 2017  Genos, ... today announced that it has received Laboratory Accreditation ... CAP Accreditation is presented to laboratories that meet ... who demonstrate scientifically rigorous processes. "Genos ... excellence in laboratory practices. We,re honored to be ...
Breaking Biology News(10 mins):